<DOC>
	<DOCNO>NCT01219556</DOCNO>
	<brief_summary>This post-marketing observational study data safety effectiveness Xirtam H collect routine clinical practice . The study objectives investigate effect Xirtam-H blood pressure achievement target blood pressure well safety satisfaction treatment . All hypertensive patient ( Blood pressure &gt; 140/90 mmHg ) investigator feels addition Xirtam H would beneficial patient included non interventional study . The routine investigation suggest attend physician do patient hypertension . No additional investigation do study purpose . The patient control exist treatment prescribe Xirtam H include study take informed consent . The patient follow 2-follow visit 6 week . The physical examination , routine investigation , blood pressure measure do data enter CRF mention CRF visit . The study plan carried 9604 patient around 300 - 350 trial site India .</brief_summary>
	<brief_title>Xirtam H Combination In Treatment Hypertension Evaluation Study .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>All Indian hypertensive patient ( Blood pressure &gt; 140/90 mm Hg ) investigator feels addition Xirtam H would beneficial patient included non interventional study . Exclusion criterion must read conjunction correspond product prescribe information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Antihypertensive Agents</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Olmesartan Medoxomil</keyword>
	<keyword>Hydrochlorothiazide</keyword>
</DOC>